Cary Street Partners Financial LLC bought a new stake in shares of MetLife, Inc. (NYSE:MET - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 22,643 shares of the financial services provider's stock, valued at approximately $1,854,000.
A number of other institutional investors and hedge funds have also recently modified their holdings of MET. United Asset Strategies Inc. raised its holdings in MetLife by 1.1% during the fourth quarter. United Asset Strategies Inc. now owns 10,933 shares of the financial services provider's stock worth $895,000 after purchasing an additional 120 shares during the last quarter. Barrett & Company Inc. grew its holdings in MetLife by 1.0% in the 4th quarter. Barrett & Company Inc. now owns 11,942 shares of the financial services provider's stock valued at $978,000 after buying an additional 121 shares during the period. Eagle Strategies LLC boosted its holdings in shares of MetLife by 4.8% in the 4th quarter. Eagle Strategies LLC now owns 2,707 shares of the financial services provider's stock valued at $222,000 after purchasing an additional 123 shares during the last quarter. J.W. Cole Advisors Inc. lifted its position in MetLife by 2.1% during the fourth quarter. J.W. Cole Advisors Inc. now owns 6,044 shares of the financial services provider's stock valued at $495,000 after buying an additional 126 shares in the last quarter. Finally, Davis R M Inc. lifted its stake in shares of MetLife by 4.2% during the fourth quarter. Davis R M Inc. now owns 3,148 shares of the financial services provider's stock worth $258,000 after purchasing an additional 127 shares in the last quarter. 94.99% of the stock is owned by institutional investors.
Analyst Ratings Changes
Several analysts have issued reports on the company. UBS Group upped their price objective on MetLife from $94.00 to $98.00 and gave the company a "buy" rating in a research note on Wednesday, April 2nd. JPMorgan Chase & Co. reduced their price objective on shares of MetLife from $88.00 to $86.00 and set an "overweight" rating for the company in a research report on Wednesday, April 2nd. Wells Fargo & Company increased their price objective on MetLife from $91.00 to $94.00 and gave the stock an "overweight" rating in a research note on Tuesday, May 6th. Keefe, Bruyette & Woods decreased their price objective on shares of MetLife from $98.00 to $95.00 and set an "outperform" rating for the company in a report on Wednesday, April 9th. Finally, Barclays decreased their price target on shares of MetLife from $95.00 to $88.00 and set an "overweight" rating for the company in a report on Friday, April 11th. One analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $92.69.
Read Our Latest Stock Analysis on MetLife
MetLife Trading Up 3.0%
MetLife stock traded up $2.32 during mid-day trading on Monday, hitting $80.17. 1,194,382 shares of the company's stock were exchanged, compared to its average volume of 3,394,619. The firm has a market capitalization of $53.82 billion, a P/E ratio of 13.43, a PEG ratio of 0.65 and a beta of 0.85. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.54. The company's 50 day simple moving average is $77.09 and its 200-day simple moving average is $81.19. MetLife, Inc. has a fifty-two week low of $65.21 and a fifty-two week high of $89.05.
MetLife (NYSE:MET - Get Free Report) last issued its quarterly earnings results on Wednesday, April 30th. The financial services provider reported $1.96 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.00 by ($0.04). MetLife had a net margin of 6.19% and a return on equity of 20.42%. The business had revenue of $18.57 billion during the quarter, compared to analyst estimates of $18.06 billion. During the same quarter in the previous year, the firm posted $1.83 earnings per share. The firm's quarterly revenue was up 15.6% on a year-over-year basis. On average, equities analysts anticipate that MetLife, Inc. will post 9.65 earnings per share for the current year.
MetLife Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 10th. Investors of record on Tuesday, May 6th will be given a dividend of $0.5675 per share. This is a positive change from MetLife's previous quarterly dividend of $0.55. This represents a $2.27 annualized dividend and a yield of 2.83%. The ex-dividend date is Tuesday, May 6th. MetLife's dividend payout ratio (DPR) is currently 36.91%.
MetLife announced that its board has approved a stock repurchase program on Wednesday, April 30th that allows the company to buyback $3.00 billion in shares. This buyback authorization allows the financial services provider to repurchase up to 5.9% of its shares through open market purchases. Shares buyback programs are typically an indication that the company's board of directors believes its stock is undervalued.
About MetLife
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Recommended Stories

Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.